Published Guidance, NICE advice and quality standards

Skip to filters Skip to results

Showing 26 to 50 of 2050

Sort by

Type: GuidanceRemove Type: Guidance filter
Type: Quality standardRemove Type: Quality standard filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Acute upper gastrointestinal bleeding in over 16s: management	CG141	13 June 2012	25 August 2016
Acutely ill adults in hospital: recognising and responding to deterioration	CG50	25 July 2007	25 July 2007
Adalimumab and dexamethasone for treating non-infectious uveitis	TA460	26 July 2017	26 July 2017
Adalimumab for the treatment of adults with psoriasis	TA146	25 June 2008	25 June 2008
Adalimumab for treating moderate to severe hidradenitis suppurativa	TA392	22 June 2016	22 June 2016
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people	TA455	12 July 2017	12 July 2017
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	14 July 2021	14 July 2021
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	26 January 2016	26 January 2016
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B	TA96	22 February 2006	22 February 2006
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I	DG32	25 April 2018	25 April 2018
Advanced breast cancer: diagnosis and treatment	CG81	23 February 2009	16 August 2017
Advocacy services for adults with health and social care needs	NG227	9 November 2022	9 November 2022
Afamelanotide for treating erythropoietic protoporphyria	HST27	26 July 2023	26 July 2023
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)	TA444	24 May 2017	24 May 2017
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	23 April 2014	23 April 2014
Aflibercept for treating choroidal neovascularisation	TA486	1 November 2017	1 November 2017
Aflibercept for treating diabetic macular oedema	TA346	22 July 2015	22 July 2015
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	28 September 2016	28 September 2016
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	26 February 2014	26 February 2014
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	TA307	25 March 2014	25 March 2014
Aflibercept solution for injection for treating wet age‑related macular degeneration	TA294	24 July 2013	24 July 2013
Age-related macular degeneration	NG82	23 January 2018	23 January 2018
Agomelatine for the treatment of major depressive episodes (terminated appraisal)	TA231	27 July 2011	27 July 2011
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images	DG55	5 July 2023	5 July 2023

Results per page

10
25
50
All